| Literature DB >> 34304236 |
Vahideh Moradi1,2, Taher Babaee3, Ardalan Shariat2, Mobina Khosravi3, Marjan Saeedi3, Jennifer Parent-Nichols4, Joshua Alan Cleland4.
Abstract
Predictive clinical and radiological factors can potentially identify adolescent idiopathic scoliosis (AIS) most likely to benefit from overcorrection nighttime bracing. These factors can provide helpful information in clinical decision making. However, the relationship between these factors and outcomes of overcorrection nighttime bracing is unclear. This systematic review determined the predictive factors for identifying outcomes of overcorrection nighttime bracing in AIS. A systematic search was conducted on PubMed, MEDLINE, Scopus, and Embase from January 1986 to January 2021. Studies on AIS patients, aged 10-18 years, with a Risser sign of 0-2 and an initial Cobb angle of 20°-45°, who were treated with overcorrection nighttime bracing and for whom at least one predictive factor of treatment outcome (failure and/or success) was assessed were included. Two blinded reviewers independently evaluated the studies using a quality assessment tool. To determine predictive factors, the level of evidence was rated through best-evidence synthesis. A total of nine studies met the inclusion criteria. A Providence brace was used in six of the included studies, while a Charleston bending brace was used in three. Findings from two high-quality studies provided strong evidence of the association between curve flexibility and brace treatment success. In terms of the Risser sign, this evidence was obtained from three high-quality studies. Moderate evidence indicated a positive association between premenarchal status and nighttime bracing failure. Inconclusive evidence indicated that poor brace compliance is associated with treatment failure. Conflicting evidence of treatment failure was indicated for initial curve magnitude, curve type, in-brace correction, age, Risser sign, curve apex, and sex. These findings show that greater curve flexibility and a higher Risser sign are associated with overcorrection nighttime bracing success.Entities:
Keywords: Adolescent idiopathic scoliosis; Nighttime bracing; Outcomes; Treatment
Year: 2021 PMID: 34304236 PMCID: PMC9441430 DOI: 10.31616/asj.2021.0037
Source DB: PubMed Journal: Asian Spine J ISSN: 1976-1902
Study characteristics
| Authors (yr) | Design | No. of patients | Age (yr) at initiation of bracing (mean) | Risser sign | Initial curve magnitude | Curve type (no.) | Type of brace | In-brace correction (%) | Brace treatment length (mo) | Months of follow-up (mean) | Definition treatment failure | Definition treatment success |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D’Amato et al. [ | Prospective | 102 | 10–16.6 (13.1) | 0–2 | 20–42 | Thoracic (24); lumbar (18); thoracolumbar (14); double (46) | Providence | Thoracic (94); lumbar (103); thoracolumbar (111); double major (90) | ≥24 | 25–81 (30) | Progression ≥6° or spinal fusion | Progression ≤5° |
| Davis et al. [ | Retrospective | 56 | 10–18 (12.26) | 0–2 | 25–40 | Thoracic (21); lumbar/thoracolumbar (23); double (12) | Providence | 88.3 | >24 | 24.1 | Progression beyond 45° or spinal fusion | Progression <5° |
| Bohl et al. [ | Retrospective | 34 | 10–15 | 0–2 | 20–40 | Thoracic (17); lumbar/thoracolumbar (9); double (8) | Providence | 90 | 12 | >12 | Progression >5°, beyond 45° or spinal fusion | NP |
| Ohrt-Nissen et al. [ | Retrospective | 63 | 10–16 (13.3) | 0–2 | 25–40 | Thoracic (37); lumbar (5); thoracolumbar (12); double (9) | Providence | 95 | ≥24 | 24 | Progression ≥6°, ≥45° or spinal fusion | Progression ≤5° |
| Ohrt-Nissen et al. [ | Retrospective | 40 | 12.1–13.5 (12.6) | 0–2 | 25–40 | Thoracic (40) | Providence | 68 | >24 | 25 | Progression ≥45° or spinal fusion | Progression ≤5° |
| Lee et al. [ | Retrospective | 95 | 10.3–16.5 (13.3) | 0–2 | 25–40 | Thoracic (37); lumbar (5); thoracolumbar (12); double (9) | Charleston | NP | 32.8 | 24–130 (46) | Progression ≥6°, ≥45° or spinal fusion | NP |
| Katz et al. [ | Retrospective | 166 | 10.1–16.6 (12.9) | 0–2 | 25–45 | Double major-primary thoracic (34); double major-primary thoracolumbar or lumbar (9); single thoracic (25); single thoracolumbar or lumbar (29); all others (57) | Providence | 83 | 25.2 | 4–51 (17) | Progression >5° or spinal fusion | Progression <5° |
| Simony et al. [ | Prospective | 80 | 13.36 | NP | 20–45 | NP | Providence | 100 | 10–36 (18) | 12 | Curve progression ≥5° or spinal fusion | No progression or a slight reduction of the curve |
| Trivedi et al. [ | Retrospective | 42 | 10–15.1 (12.5) | 0–1 | 25–40 (30.3) | Thoracic (17); lumbar (3); thoracolumbar (22) | Charleston | 114 | Successful group:13–139 (40); unsuccessful group: 6–86 (36) | NP | Curve progression >5° or necessary to change to full-time bracing | Progression <5° |
NP, not provided.
Methodological quality assessment criteria
| Quality criteria | Score |
|---|---|
| Study population | |
| A) Description of source population | 1 |
| B) Valid inclusion and exclusion criteria | 1 |
| C) Sufficient description of baseline characteristics | 1 |
| Follow-up | |
| D) Follow-up of at least 1 year | 1 |
| E) Prospective or retrospective data collection | 1 |
| F) Loss to follow-up ≤20% | 1 |
| G) Information about loss to follow-up (selective for age, sex, or severity) | 1 |
| Exposure | |
| H) Exposure assessment blinded for the outcome | 1 |
| I) Exposure measured identically in the studied population at baseline and follow-up | 1 |
| Outcome | |
| J) Outcome assessment blinded for exposure | 1 |
| K) Outcome measured identically in the studied population at baseline and follow-up | 1 |
| Analysis | |
| L) Measure of association or measures of variance given | 1 |
| M) Adjusted for age, sex and severity | 1 |
Quality assessment of the included studies
| Included studies | Items of quality assessment[ | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | B | C | D | E | F | G | H | I | J | K | L | M | Total score | Quality | |
| Bohl et al. [ | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 7 | Low |
| D’Amato et al. [ | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 9 | High |
| Ohrt-Nissen et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 10 | High |
| Ohrt-Nissen et al. [ | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 9 | High |
| Katz et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 10 | High |
| Lee et al. [ | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 8 | Low |
| Simony et al. [ | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 8 | Low |
| Trivedi et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 8 | Low |
| Davis et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 9 | High |
The items are shown in Table 2.
Fig. 1Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) diagram.
Clinical and radiographic parameters for outcome of the brace treatment
| Variable | Study | Study quality | Assessment approach | Significance level | Association with treatment success | Level of evidence for treatment success | Association with treatment failure | Level of evidence for treatment failure |
|---|---|---|---|---|---|---|---|---|
| Initial curve magnitude | D’Amato et al. [ | High | Radiography | NP | - | Conflicting | NE | Conflicting |
| Bohl et al. [ | Low | Radiography | NE | NR | ||||
| Ohrt-Nissen et al. [ | High | Radiography | NR | NR | ||||
| Ohrt-Nissen et al. [ | High | Radiography | NE | + | ||||
| Katz et al. [ | High | Radiography | NP | - | + | |||
| Davis et al. [ | High | Radiography | - | + | ||||
| Lee et al. [ | Low | Radiography | NR | NE | ||||
| Simony et al. [ | Low | Radiography | NR | + | ||||
| Trivedi et al. [ | Low | Radiography | NR | NE | ||||
| Curve type | Lee et al. [ | Low | Radiography | NR | Inconclusive | NE | Conflicting | |
| Trivedi et al. [ | Low | Radiography | NR | NE | ||||
| Ohrt-Nissen et al. [ | High | Radiography | NE | + | ||||
| Katz et al. [ | High | Radiography | NP | + | + | |||
| Davis et al. [ | High | Radiography | NE | NR | ||||
| Bohl et al. [ | Low | Radiography | NE | NR | ||||
| In-brace correction | D’Amato et al. [ | High | Radiography | + | Conflicting | NE | Conflicting | |
| Ohrt-Nissen et al. [ | High | Radiography | + | NE | ||||
| Davis et al. [ | High | Radiography | NR | NR | ||||
| Katz et al. [ | High | Radiography | + | - | ||||
| Simony et al. [ | Low | Radiography | NP | + | - | |||
| Trivedi et al. [ | Low | Radiography | NR | NR | ||||
| Curve flexibility | D’Amato et al. [ | High | Radiography | + | Strong | NE | No association: limited | |
| Ohrt-Nissen et al. [ | High | Radiography | + | NR | ||||
| Age | D’Amato et al. [ | High | Continues | NP | + | Conflicting | NE | Conflicting |
| Ohrt-Nissen et al. [ | High | Continues | NR | + | ||||
| Ohrt-Nissen et al. [ | High | Continues | NE | NR | ||||
| Bohl et al. [ | Low | Categorized | NE | NR | ||||
| Risser sign | D’Amato et al. [ | High | Radiography | + | Strong | NE | Strong | |
| Lee et al. [ | Low | Radiography | NR | NE | ||||
| Katz et al. [ | High | Radiography | NP | + | - | |||
| Davis et al. [ | High | Radiography | + | - | ||||
| Bohl et al. [ | Low | Radiography | NE | NR | ||||
| Premenarchal status | Ohrt-Nissen et al. [ | High | Pre/post menarche | NE | - | + | Moderate | |
| Compliance | Bohl et al. [ | Low | Self-reported | NE | - | - | Inconclusive | |
| Curve apex | D’Amato et al. [ | High | Radiography | + | Conflicting | NE | Conflicting | |
| Davis et al. [ | High | Radiography | + (for T10–L3) | + (for T6–T9) | ||||
| Bohl et al. [ | Low | Radiography | NE | NR | ||||
| Lee et al. [ | Low | Radiography | NR | NE | ||||
| Sex | Bohl et al. [ | Low | Male-female | NE | Conflicting | + | Conflicting | |
| Davis et al. [ | High | Male-female | NR | NR |
NP, not provided; OR, odds ratio; NE, not evaluated; NR, no relationship; +, positive relationship; -, negative relationship.